CIRUGÍA
Departamento
University College London Hospitals NHS Foundation Trust
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de University College London Hospitals NHS Foundation Trust (2)
2023
-
One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medications
Neurourology and Urodynamics, Vol. 42, Núm. 6, pp. 1203-1213
2021
-
OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice
International Urogynecology Journal, Vol. 32, Núm. 1, pp. 65-74